HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Functional study of a gene candidate for Landouzy-Dejerine muscular dystrophy].

Abstract
Facioscapulohumeral muscular dystrophy (FSHD) or Landouzy Dejerine muscular dystrophy affects one in 20,000 individuals. It is characterized by a progressive degeneration of skeletal muscles that progresses asymmetrically from the upper to the lower parts of the body. Although the genetic defect has been known for twelve years, the causative gene has not been identified. Patients exhibit a partial deletion in a series of repeated elements mapping close to the end of the chromosome 4 long arm. Investigators believe this deletion disturbs chromatin structure over a long distance, affecting the expression of several genes. Our laboratory has identified a gene within the repeated element itself. This gene is functional and encodes a protein, DUX4, located at the periphery of the cell nucleus. DUX4 is detected in small amounts in primary myoblasts cultures of patient but not of non-affected individuals. Its forced expression in control cells causes cell death within 48 hours. Patient primary myoblasts present oxidative stress: this phenomenon is also induced by DUX4 forced expression. In conclusion, we propose the DUX4 gene as a candidate for FSHD.
AuthorsA Belayew
JournalBulletin et memoires de l'Academie royale de medecine de Belgique (Bull Mem Acad R Med Belg) Vol. 159 Issue 5-6 Pg. 343-8; discussion 348-9 ( 2004) ISSN: 0377-8231 [Print] Belgium
Vernacular TitleEtude fonctionnelle d'un gène candidat pour la dystrophie musculaire de Landouzy-Dejerine.
PMID15693543 (Publication Type: Lecture, Research Support, Non-U.S. Gov't)
Topics
  • Humans
  • Muscular Dystrophies (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: